Ennov is an independent software vendor (ISV) specialized in regulated content management for Life Science companies. On top of a generic EDMS / BPMS / Analytics / MDM technology platform (usable in any sector), we propose 5 sets of solutions uniquely tailored for the Life Sciences market: - Quality Management Systems (quality documents, processes, training management) - Regulatory Compliance Solutions (Regulatory Documents, eCTD, RIM, IDMP) - Clinical Trial Management Software (eTMF, EDMS, EDC, CTMS, RTSM, ePRO) - Pharmacovigilance system (PV database for human and animal health, signal detection and signal management) - Pharmaceutical Event Management (Planning, Tracking, regulatory compliance and Contract management) We have more than 450 clients worldwide (200+ in Life Science) and 20 years of experience serving the Pharmaceutical, Medical Device, Cosmetic and Healthcare Industries. Our single focus: delivering cost effective, best-of-breed, off the shelf, highly configurable, user friendly solutions to our clients. Ennov helps organizations comply with external and internal regulations to gain the true value of their business content. Highly scalable yet easily implemented, the Ennov product line requires minimal use of IT infrastructure and resources. All Ennov solutions include built-in electronic signature and audit trail compliant with the FDA 21 CFR Part 11, LDAP synchronization, scanner connector, email connector. Ennov solutions are web based solutions but can be installed on premise or used as cloud based solutions.
Looking for a particular Ennov employee's phone or email?
The Ennov annual revenue was $94.5 million in 2026.
James Deleuse is the Chief Product Officer of Ennov.
269 people are employed at Ennov.
Ennov is based in Paris, Île-de-France.
The NAICS codes for Ennov are [5112, 513, 51, 511].
The SIC codes for Ennov are [73, 737].